Literature DB >> 16270404

Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma.

Kazuhiro Kaneko1, Yoshio Shirai, Toshifumi Wakai, Naoyuki Yokoyama, Kohei Akazawa, Katsuyoshi Hatakeyama.   

Abstract

AIM: To assess the validity of our selection criteria for hepatectomy procedures based on indocyanine green disappearance rate (K(ICG)), and to unveil the factors affecting posthepatectomy mortality in patients with hepatocellular carcinoma (HCC).
METHODS: A retrospective analysis of 198 consecutive patients with HCC who underwent partial hepatectomies in the past 14 years was conducted. The selection criteria for hepatectomy procedures during the study period were K(ICG)>or=0.12 for hemihepatectomy, K(ICG)>or=0.10 for bisegmentectomy, K(ICG)>or=0.08 for monosegmentectomy, and K(ICG)>or=0.06 for nonanatomic hepatectomy. The hepatectomies were categorized into three types: major hepatectomy (hemihepatectomy or a more extensive procedure), bisegmentectomy, and limited hepatectomy. Univariate (Fisher's exact test) and multivariate (the logistic regression model) analyses were used.
RESULTS: Postoperative mortality was 5% after major hepatectomy, 3% after bisegmentectomy, and 3% after limited hepatectomy. The three percentages were comparable (P = 0.876). The platelet count of <or=10X10(4)/microL was the strongest independent factor for postoperative mortality on univariate (P = 0.001) and multivariate (risk ratio, 12.5; P = 0.029) analyses. No patient with a platelet count of >7.3X10(4)/microL died of postoperative morbidity, whereas 25% (6/24 patients) of patients with a platelet count of <or=7.3X10(4)/microL died (P<0.001).
CONCLUSION: The selection criteria for hepatectomy procedures based on K(ICG) are generally considered valid, because of the acceptable morbidity and mortality with these criteria. The preoperative platelet count independently affects morbidity and mortality after hepatectomy, suggesting that a combination of K(ICG) and platelet count would further reduce postoperative mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270404      PMCID: PMC4479695          DOI: 10.3748/wjg.v11.i37.5888

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Hepatic resection using the harmonic scalpel.

Authors:  H Sugo; Y Mikami; F Matsumoto; H Tsumura; Y Watanabe; K Kojima; S Futagawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma.

Authors:  Wei Wu; Xin-Bao Lin; Jian-Min Qian; Zhen-Ling Ji; Zao Jiang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

3.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

4.  One hundred hepatic resections. Indications and operative results.

Authors:  T Nagao; S Inoue; T Mizuta; H Saito; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

5.  Estimation of risk of major complications after hepatic resection.

Authors:  M Shimada; T Matsumata; K Akazawa; T Kamakura; H Itasaka; K Sugimachi; Y Nose
Journal:  Am J Surg       Date:  1994-04       Impact factor: 2.565

6.  Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma.

Authors:  T Matsumata; T Kanematsu; K Shirabe; T Sonoda; T Furuta; K Sugimachi
Journal:  Br J Surg       Date:  1990-06       Impact factor: 6.939

7.  Central venous pressure and its effect on blood loss during liver resection.

Authors:  R M Jones; C E Moulton; K J Hardy
Journal:  Br J Surg       Date:  1998-08       Impact factor: 6.939

8.  Assessment of hepatic reserve for indication of hepatic resection: how I do it.

Authors:  Ronnie T Poon; Sheung Tat Fan
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

9.  Estimation of the functional reserve of human liver.

Authors:  F G Moody; L F Rikkers; J S Aldrete
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

10.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Authors:  S T Fan; E C Lai; C M Lo; I O Ng; J Wong
Journal:  Arch Surg       Date:  1995-02
View more
  14 in total

1.  Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis.

Authors:  Shishir K Maithel; Peter J Kneuertz; David A Kooby; Charles R Scoggins; Sharon M Weber; Robert C G Martin; Kelly M McMasters; Clifford S Cho; Emily R Winslow; William C Wood; Charles A Staley
Journal:  J Am Coll Surg       Date:  2011-04       Impact factor: 6.113

Review 2.  A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery.

Authors:  Chris D Mann; Tom Palser; Chris D Briggs; Iain Cameron; Myrrdin Rees; John Buckles; David P Berry
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

3.  Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy.

Authors:  Hai-Qing Wang; Jian Yang; Jia-Yin Yang; Wen-Tao Wang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 4.  Issues to be considered to address the future liver remnant prior to major hepatectomy.

Authors:  Yoji Kishi; Jean-Nicolas Vauthey
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

5.  Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study.

Authors:  Motoi Azumi; Takeshi Suda; Shuji Terai; Kouhei Akazawa
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

6.  Impaired liver function attenuates liver regeneration and hypertrophy after portal vein embolization.

Authors:  Yumiko Kageyama; Takashi Kokudo; Katsumi Amikura; Yoshihiro Miyazaki; Amane Takahashi; Hirohiko Sakamoto
Journal:  World J Hepatol       Date:  2016-10-08

7.  Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma.

Authors:  Ken Min Chin; John Carson Allen; Jin Yao Teo; Juinn Huar Kam; Ek Khoon Tan; Yexin Koh; Kim Poh Brian Goh; Peng Chung Cheow; Prema Raj; Kah Hoe Pierce Chow; Yaw Fui Alexander Chung; London Lucien Ooi; Chung Yip Chan; Ser Yee Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-08-31

Review 8.  Advances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their Origin.

Authors:  Ali-Reza Sadri; Marc G Jeschke; Saeid Amini-Nik
Journal:  Stem Cells Int       Date:  2015-12-20       Impact factor: 5.443

9.  How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.

Authors:  Ching-Hsin Lee; Sheng-Ping Hung; Ji-Hong Hong; Joseph Tung-Chieh Chang; Ngan-Ming Tsang; Kun-Ming Chan; Jeng-Hwei Tseng; Shih-Chiang Huang; Shi-Ming Lin; Jau-Min Lien; Nai-Jen Liu; Chen-Chun Lin; Wei-Ting Chen; Wan-Yu Chen; Po-Jui Chen; Bing-Shen Huang
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

10.  Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery.

Authors:  Rory L Smoot; Thomas Gruenberger; Patrick Starlinger; David Pereyra; Hubert Hackl; Gregor Ortmayr; Eva Braunwarth; Jonas Santol; Sina Najarnia; Michael R Driedger; Lindsey Gregory; Roberto Alva-Ruiz; Amy Glasgow; Alice Assinger; David M Nagorney; Elizabeth B Habermann; Stefan Staetttner; Sean P Cleary
Journal:  Hepatology       Date:  2021-03-16       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.